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1. Executive summary 
This study is an exploration of developments in “green” (plant) biotechnology for the purpose of policy 
development and updating risk assessment of GMOs and biotechnology in general in the Netherlands. 
The study is based on a literature review and interviews with stakeholders. The developments encompass 
both novel techniques such as genome editing and new concepts or applications for already established 
techniques such as plant transformation (transgenic plants). Intended and unintended effects are 
discussed, but risk assessment and regulatory issues are not, since they are out of the scope of this 
inventory.  
The overview of developments in plant biotechnology is presented as a listing of techniques and/or 
concepts (see Table 1):  
 Genome editing generates mutations in specifically targeted genomic sequences, such as genes 
or gene promoters. This can be performed by introducing sequence-specific oligo nucleotides 
into plant cells (protoplasts) in oligo-directed mutagenesis (ODM). Alternatively, sequence-
specific nucleases (SSNs) are used that make double-strand breaks followed by repair (non-
homologous end-joining NHEJ) leading to local changes in the sequence. The presently most 
notable SSN is CRISPR-Cas. The SSNs can also be used for introduction of larger sequences, 
including genes or alleles, by using a homologous recombination (HR) repair mechanism.  
 Alternative uses of classical transformation technology: Using transgenic plant lines without the 
transgene becoming part of the final plant product can for instance be applied to speed up 
breeding in crops with long generation times, e.g. trees that only start flowering a few years 
after seed germination. Transgenic lines that start flowering in their first year are used to speed 
up a crossing scheme to introduce new traits into elite plant material. By selecting against the 
transgene during the final crossing steps, a plant product (variety) is obtained that does not 
contain the transgene anymore. These are also called “null segregants”. Such methods can also 
be applied in various forms in hybrid variety breeding. Cisgenesis and intragenesis, which are 
concepts of classical transformation using only genes from cross-compatible species are also 
considered in this study.  
 RNAi (RNA interference) targets specific genomic sequences as in genome editing, but in this 
case genes are silenced using RNA interference constructs. This can be applied in two ways: (I) 
by generating small RNAs directed at specific mRNAs inhibiting their translation into proteins 
(post-transcriptional gene silencing (PTGS)); or (II) by generating small RNAs directed at 
specific gene promoters effecting DNA methylation in turn leading to silencing of gene 
transcription of mRNA (transcriptional gene silencing (TGS), also designated as RNA-directed 
DNA methylation (RdDM).  
 Synthetic biology involves creating plant parts by design, such as artificial chromosomes. It is 
not always clearly defined. In this inventory, we have discussed novel metabolic pathways based 
on classical plant transformation in this category.  
 We briefly discuss remaining categories of external compounds directing gene expression and an 
additional development in grafted plants.  
There are many cross-connections among these techniques and concepts that are shown in an 
alternative scheme in Table 2. The scheme is based on the way transgenic constructs are used: plants 
with stable transgene insertion(s) into their genome (e.g. RNAi, particularly PTGS), with initial transgene 
insertion, but followed by subsequent removal of the transgenic constructs (e.g. the early flowering), and 
transient expression (no insertion of transgenes into the genome) or introducing only (ribo)proteins or 
RNA into the plant cell for changing traits by genome editing (DNA-free genome editing).  
Genome editing and RNAi target existing (“native”) plant genes. An exception is the application of 
genome editing by homologous recombination (HR) using “foreign” sequences as template. ODM can 
produce gene knock-outs and small changes of one amino acid. Genome editing using SSNs following the 
non-homologous end joining (NHEJ) pathway will mainly produce gene knock-outs and genome editing 
by HR enables to produce precise changes, from small sequence changes up to complete allelic or (novel) 
gene sequences. With RNAi, gene knock-downs are produced by silencing the expression of native genes, 
but as opposed to genome editing knock-outs, they will inherit dominantly, as long as the silencing 
(RNAi-) construct is present in the plant line. This means that the trait is always effective (also at a 
heterozygous state), as opposed to gene knock-outs that are only expressed in a homozygous (recessive 
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state), i.e. with all alleles of a gene being defective in expression. Silencing using RNAi will often not be 
absolute, but this may be advantageous for traits where complete knocking out of the gene function has 
undesirable side effects. Among these traits, an interesting example is resistance to insects or pathogens 
through “cross-kingdom” RNAi, i.e. post-transcriptional gene silencing (PTGS) by a transgenic construct 
targeting gene sequences of the pathogen or pest, also called host-induced gene silencing (HIGS). It 
represents a novel type of trait, though exchange of small RNAs between organisms is an existing 
phenomenon. Enabling technologies of next generation sequencing (NGS) and bioinformatics will 
increase the ability to find target organism-specific sequences. These enabling technologies are also 
helpful with the other techniques, for example by identifying genes interesting for changing expression 
by genome editing or RNAi, or for targeted introduction by e.g. SSN - HR.  
As in classical plant transformation, in the new developments of green biotechnology, intended and 
unintended effects will largely depend on the type of new trait introduced or generated and so will vary 
from case to case. Most techniques enable changing a wide variety of traits, for instance, abiotic stress 
tolerances (e.g. for drought or salt), disease resistances (e.g. against bacteria or fungi) or metabolic 
changes underlying product quality.  
Depending on the specific SSN variant, off-target mutations (unintended modifications at other 
chromosomal locations) may occur to a certain extent. For CRISPR-Cas9, improvements have been made 
in order to reduce the off-target effects. In addition, such effects could now be identified more efficiently 
using the enabling technologies of NGS and bioinformatics. Likewise with RNAi, off-target silencing also 
appears to be possible. Nevertheless, genome editing (and for that matter, gene silencing) is expected to 
be basically more precise than “classical” mutagenesis as it is targeted at specific sequences in the 
genome. “Classical” mutagenesis induces multiple random mutations in the genome among which the 
trait of interest needs to be selected and subsequent plant breeding is used to apply extensive 
phenotypic and increasingly genotypic testing for selecting elite materials for commercialization.  
Drivers behind many of the new techniques or concepts discussed in this report appear to be of a 
dualistic nature. From a technical point of view, they primarily aim at improving the efficiency and/or 
precision of breeding, but the possibility of simplifying regulatory oversight is also of relevance, in that 
they mostly avoid the presence of transgenes in the final plant product (cf. Table 2). In particular 
examples, such as early flowering for faster crossing schemes, removing the transgenic construct is also 
an essential part of the technique as the expression of genes that are present on the transgenic 
construct is unwanted in the final plant product. As a result of both drivers, unintended effects associated 
with plant transformation will be minimized. For SSN-based genome editing techniques there is even an 
alternative to avoid inserting a transgenic construct into the genome: employing transient expression of 
the construct encoding the SSN in protoplasts or introducing mRNAs coding for the SSN proteins or the 
SSN proteins  and/or gRNAs directly into protoplasts (“DNA-free” genome editing). For the “null 
segregant” approaches, including those in RNAi (e.g. RdDM), an alternative is introducing expression 
constructs through virus vectors that will not end up in the progeny as they are not transmitted during 
seed formation.  
Predictions on future developments in green biotechnology are accompanied by uncertainty or can be 
incomplete, as exemplified by the recent rise of CRISPR-Cas, which was unknown as a genome editing 
tool in plants just five years ago. As already seen in classical plant transformation (transgenic plants), 
promising applications need to go through the stringent process - basic to all innovations - of achieving 
commercial viability, including competition with alternative approaches. For instance, amongst others, 
“cross-kingdom” RNAi may have to compete with alternative modes of application using sprays 
containing the interfering RNAs. A practical problem with predicting the likelihood of development into 
commercial products is the barrier perceived in their regulatory status as a GM or not. The costs and/or 
uncertainty around the consequences of regulation are perceived as such a burden that breeders will 
likely not use novel technologies commercially when they would fall under present GM regulation or as 
long as there is uncertainty about this in the EU. In an attempt to be still informative, Table 3 presents 
an overview of the techniques with an attempt to depict the horizon of applications, disregarding the 
expected impact of regulation in the EU as far as possible. The most likely techniques to show strong 
developments in the near future are the genome editing techniques, in particular CRISPR-Cas9. The HR 
variant could be most precise and versatile but is still technically demanding in plants. The “null 
segregant” concepts are promising for accelerating the breeding process and for several processes 
underlying production of hybrid seed varieties. Some RNAi applications are already on the market outside 
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of the EU and others may become relevant in the near future, e.g. “cross-kingdom” RNAi (HIGS) with an 
insect example recently deregulated in the US. But others, e.g. transcriptional gene silencing TGS (based 
on RNA-dependent DNA methylation RdDM), at least in their variant of the end product not containing 
the transgenic silencing construct, are still awaiting effective examples. Applications in metabolic 
engineering may become relevant soon, particularly in bio-fortification and bio-based economy, and for 
producing pharmaceuticals.  
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2. Introduction 
This study entails an exploration of developments in “green” biotechnology, alongside other such 
inventories for the “white” (industrial) and “red” (medicinal) biotechnology executed by other research 
teams, for the purpose of policy development and updating risk assessment of GMOs and products of 
biotechnology in general in the Netherlands. The development that drew most attention in plant 
biotechnology in recent years has been the introduction of various novel technologies aiming at 
improving the precision of introduced changes in the plant genome and/or the efficiency of plant 
breeding. At the same time, some of these technologies raised questions as to how to define their 
products with regard to the existing definitions of a genetically modified organism (see the list in Lusser 
et al. 2012). These technologies comprised new tools, such as targeted genome editing, as well as new 
concepts, such as the use of transformed plants to improve the efficiency of the breeding process without 
transgene(s) being present in the final plant product. However, the ongoing expansion of plant 
biotechnology covers more than these techniques. There are also interesting developments in “classical” 
genetic modification (plant transformation), such as the application of RNAi (RNA interference) for the 
control of pests and pathogens. In addition, enabling technologies, particularly a rapid succession of 
generations of DNA sequencing technology combined with bioinformatics, are quickly expanding the 
knowledge of plant genomes, which in turn helps in refining the technologies modifying genomes. In 
addition, the end products of new technologies, such as genome editing1, can be screened more 
extensively for the presence of any off-target effects. Moreover, sequencing opens up new ways of 
screening for useful genetic variation, which drives technological developments regarding how to make 
use of such variation as quickly and effectively as possible.  
For the purposes of this inventory, we address techniques and concepts aimed at changing genomes and 
gene expression in higher (crop) plants in a heritable fashion. We will also briefly mention other methods 
affecting gene expression, e.g. application of various types of non-coding RNA without transformation, 
but only for comparison to similar processes enabled by genomic changes. Enabling technologies will be 
mentioned in so far as they may play a role as driver in the developments that form the primary subject 
of this inventory. We will describe most extensively the techniques for applications that will be found to 
be probably closest to marketable plant products. We will discuss the intended and unintended effects 
reported for the respective techniques, but risk assessment and legal issues are out of the scope of this 
inventory. Nevertheless, regulatory issues will be mentioned as they are often cited as barriers to 
commercial application of techniques. Thus, for each technique or concept, we will give (I) a technical 
description; (II) an overview of host effects, intended and unintended; (III) areas of application; (IV) 
barriers and drivers for further development of the technique/concept in the EU; (V) the horizon, i.e. 
what products are to be expected in the near future in the EU.  
 
 
  
                                                          
 
1
 Some authors prefer “gene editing” as the edits concern particular sites and not the entire genome 
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3. Method description and list of techniques 
This exploration encompasses in the first place a literature review. We scanned the primary scientific 
literature using terms for the new technologies (see Table 1) in combinations with (un)intended or off-
target effects, and additionally consulted review journals addressing plant biotechnology for obtaining an 
overview of any new developments. Next to this, we consulted plant breeding colleagues and companies. 
For the consultation of companies, we used a list of techniques/developments possibly relevant for 
product development and asked each of them to what extent they would lead to marketable products in 
the short and medium term. We also asked about drivers and barriers for each of the techniques and 
whether they foresee any other new development that was not yet on the list. The list of techniques and 
developments as used in the interviews and the interview questions are in the annex. Due to time 
limitations, we interviewed two sector organizations, Plantum and HollandBio, which in turn consulted 
their members, among which large companies and SMEs in vegetable, arable and ornamental crops, and 
one plant technology developer, KeyGene. The interview results were used anonymously in this report.  
The focus of this inventory was on higher (crop) plants. The highly diverse algae, including the green 
algae that are most closely related to higher plants, are nowadays receiving more attention for bio-based 
economy purposes, but they were not part of this study. Also (plant) pest control through genetic 
modification of the target (pest) organisms themselves was outside the scope of this study.  
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Table 1. List of new techniques and/or developments in plant (“green”) biotechnology. 
Theme Techniques Mode of action/examples Special 
Genome 
editing 
Oligo-directed 
mutagenesis (ODM) 
 inducing site-specific changes in 
the DNA using oligonucleotides 
with mismatches as template: 
indels, nucleotide substitutions 
 
Genome 
editing 
Sequence-specific 
nucleases (SSNs): non-
homologous end joining 
(NHEJ) 
 inducing site-specific double 
strand breaks (DSBs) resulting in 
homologous-independent DNA 
repair by NHEJ using SSNs 
(ZFN, Meganuclease, TALENS, 
CRISPR-Cas9): indels, 
nucleotide substitutions  
variant: “DNA-free” 
genome editing by 
transient 
expression or 
delivery of 
(ribonucleo)protein 
or mRNA in cells 
Genome 
editing 
Sequence-specific 
nucleases (SSNs): 
homologous 
recombination (HR) 
 inducing site-specific double 
strand breaks (DSBs) resulting in 
homologous-driven repair by HR 
using SSNs: targeted gene 
insertion, allele replacement 
 
Plant 
transformation 
(new variants) 
Plant transformation 
with transgenes not in 
end product 
 Induced early flowering for 
accelerated breeding in fruit 
trees;  
 Suppression of meiotic 
recombination (reverse 
breeding), maintainer lines, or 
haploid inducers for hybrid 
breeding;  
 transgenic rootstocks 
 
Plant 
transformation 
(new variants) 
Plant transformation 
introducing genes from 
cross-compatible 
species 
 Cisgenesis: introduction of genes 
from same or cross-compatible 
species  
 Intragenesis: introduction of 
novel combinations of genes & 
promoters from same or cross-
compatible species 
 
RNAi Post-transcriptional 
gene silencing (PTGS) 
 overexpression of gene-derived 
inverted repeats (dsRNA) for 
silencing gene expression: 
degradation of mRNA or 
translational repression directed 
by siRNAs or miRNAs 
“Cross-kingdom 
RNAi”: RNAi 
against pests and 
pathogens (host 
induced gene 
silencing HIGS) 
Special variants 
using transformed 
rootstock to deliver 
siRNA to non-GM 
scion 
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RNAi Transcriptional gene 
silencing (TGS) 
 gene silencing by promoter 
methylation induced by dsRNA 
from transgene subsequently 
removed from end product 
(RdDM) 
Special variants: 
Induced using virus 
not carried over 
through meiosis.  
Mobile small RNAs 
moving between 
shoot & root 
(grafted plants, 
possibility of 
regenerating 
epigenetically 
changed plant from 
non-GM part) 
Synthetic 
biology 
  Synthetic chromosomes  
 Site-specific 
activators/repressors (targeted 
activation or repression of gene 
expression by artificial factors 
affecting transcription or inducing 
epigenetic changes using 
combinations of active domains 
with SSN-derived DNA-binding 
domains)  
 Introduction of novel pathways; 
"plant as factory" 
(pharmaceuticals/antibodies)  
 Adapting CRISPR-Cas9 to 
targeting plant DNA viruses 
 
    
Method of 
delivery 
Modifying gene 
expression without 
transformation 
 Gene silencing by application of 
dsRNA:  
o to plant (parts);  
o to insects/pathogens  
 Agro-inoculation, VIGS  
 “DNA-free” genome editing (by 
SSN delivery as 
(ribonucleo)protein, mRNA or 
transient expression of SSN-
genes in cells 
Special variant: 
early flowering by 
promoting or 
silencing gene 
expression through 
virus vector not 
transmitted to 
progeny 
    
Other   regenerating species hybrid from 
graft junction 
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4. Techniques 
4.1. Genome editing using oligonucleotide-directed mutagenesis (ODM) 
 
Technical description 
ODM introduces specific mutations at defined locations in the plant genome. For ODM synthetic 
oligonucleotides homologous to the target DNA, but containing mismatches, are introduced into plant 
cells. The mismatches in base pairing between the single-stranded oligonucleotide and target DNA are 
corrected by the plant’s native repair mechanism, resulting in point mutations in the targeted DNA, which 
can be nucleotide substitutions or small indels, leading to an altered protein coding sequence, or a 
premature translational stop. The synthetic oligo’s consist of both DNA and modified nucleotides or other 
end-protective chemistries. These modifications prevent the oligonucleotides from undergoing 
recombination (i.e., being incorporated into the genome), while maintaining the ability to act as a 
mutagen (Sauer et al. 2016). Once the correction process is completed, the oligos are degraded. In in 
vitro assays using “cell-free” extracts and various pure enzymes, it was demonstrated that the oligos are 
stable for sufficient time to direct gene correction and then are quickly degraded (Gocal et al. 2015).  
Host effects  
Genome editing by ODM leads to variants of native genes or knock-out mutants. As effective ODM 
requires long (>40 nt) oligos, (which are aside from the intended mismatch(es) fully complementary to 
the target sequence), off-target mutations (the unintended modifications at other chromosomal 
locations) are not expected. Information about any ODM off-target effects is however limited. Cole-
Strauss et al. (1996) and Xiang et al. (1997) demonstrated the specificity of ODM by showing that when 
targeting the ß-globin locus, closely related homologous globin gene sequences remained unaltered. We 
have found no other studies studying potential off-target effects of ODM.  
Application areas  
Because the efficiency of gene modification by ODM is low, to date all published examples using ODM in 
plants aimed at an efficiently selectable, herbicide-tolerant (HT) phenotype. In maize, canola, and oilseed 
rape plants, tolerance to imidazolinone herbicides has been engineered through targeted mutagenesis of 
the endogenous acetolactate synthase (ALS) gene, also known as the acetohydroxy acid synthase 
(AHAS) gene (Zhu et al. 2000). KeyGene reports that they have increased the efficiency of their system 
KeyBase up to about 1%, which would enable generating mutations in non-selectable types of traits, 
significantly broadening the usage of the technique.  
Barriers and drivers 
The requirement of specific tissue culture technology (protoplast technology; biolistic delivery) remains a 
barrier to a widespread application of this technique. Successful regeneration of plants from protoplasts 
is only applicable to a limited number of crop species (but including important crops such as tomato, 
potato and lettuce) and success rates are genotype-dependent (Eeckhaut et al. 2013). Targeting genes 
that are non-selectable during the ODM process and plant regeneration require high repair efficiencies, 
which are difficult to realize. A driver is that it represents a precise mutagenesis method that does not 
involve the use of transgenic constructs.  
Horizon 
Two companies, Cibus and KeyGene (http://www.keygene.com/products-tech/keybase/), are known to 
work on development and application of ODM for genome editing in plants. Cibus has produced 
herbicide-tolerant oilseed rape using ODM (which they call ‘Rapid Trait Development System’, RTDS), 
which is commercialized in the United States and Canada (http://cibus.com/press/press031814.php). 
Interviewees indicated that ODM could be attractive as no transgenic constructs are introduced and 
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therefore, it could be seen as the genome editing method farthest away from classical plant 
transformation. Competent authorities in six EU member states (IE, UK, ES, DE, FI and SE) have 
indicated that they do not consider (specific cases of) ODM to fall under GM regulation by Directive 
2001/18/EC. Thus, Cibus performed field trials in the UK and SE, apparently without regulatory 
oversight, but has stopped these activities awaiting the legal analysis by the European Commission 
(Abbott 2015). When ODM would be considered as falling under the Directive 2001/18/EC, this would be 
expected to be prohibitive for commercial applications.  
Increased gene targeting efficiencies will allow modification of other types of traits, such as disease 
resistances and product quality improvements, for which selection in tissue culture systems is not 
possible.  
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4.2. Genome editing using sequence-specific nucleases (SSNs): non-homologous end 
joining (NHEJ pathway) 
 
Technical description  
Using SSN (sequence-specific nuclease) technology followed by non-homologous end joining (NHEJ)-
mediated repair, any gene of interest can be stably knocked out or mutated. Zinc Finger Nucleases 
(ZFNs), Meganucleases, TALENs and CRISPR-Cas are examples of SSNs. SSNs are also called site-
directed nucleases (SDNs). SSNs bind to a predefined target DNA sequence at which location they induce 
a double-strand break (DSB). Repair of the DSB by the native NHEJ pathway often results in a small 
insertion or deletion (indel) at the target site. Less frequently larger (20-200bp) deletions are induced. 
The indels are often bi- (or multi-) allelic, i.e., all copies of the gene are mutated in one regenerated 
plant. With the simultaneous use of two or more SSNs, multiple genes may be targeted at the same 
time. This is especially effective with CRISPR-Cas. The SSN constructs used are not required anymore 
after the modifications have been introduced. In case the constructs were incorporated as transgenic 
sequences they may be removed from the modified plant e.g. by segregation after crossing. Genome 
editing using SSNs, and especially using CRISPR-Cas, in plants has extensively being reviewed recently 
(see e.g. Fichtner et al. 2014; Puchta and Fauser 2014; Chen and Gao 2014; Bortesi and Fischer 2015; 
Osakabe and Osakabe 2015).  
Host effects  
Application of SSNs without a repair template can induce small indels in coding sequences resulting in 
premature stop of translation (knock-out mutants) or in translation into proteins with an altered amino 
acid sequence (amino acid substitutions or deletions of a few amino acids). If SSNs are targeted to the 
promoter sequence of a gene, the removal of specific promoter elements may result in gene variants 
with a changed gene expression pattern (Li et al. 2012). The application of a combination of SSNs can 
result in chromosomal rearrangements, such as deletions (Zhou et al. 2014), inversions, duplications 
(Lee et al. 2012) (up to a few megabasepairs) and translocations (Blasco et al. 2014; Choi and Meyerson 
2014, Puchta and Fauser 2014). This may affect gene function, but may also have an impact on meiotic 
recombination (Rieseberg 2001). Off-target effects (unintended modifications at other chromosomal 
locations) can play a role when applying genome editing using SSNs. For TALENs off-target effects are 
relatively rare and depend on the number of repeats used (each repeat binds specifically to a single 
nucleotide). For both ZFNs and CRISPR-Cas higher frequencies of off-target effects have been reported 
(Fichtner et al. 2014). With CRISPR-Cas9, newly developed Cas9-variants with improved binding of 
target or non-target DNA strand to the Cas9-protein (eCas9 (Slaymaker et al. 2016); Cas9-HF1 (Hifi, 
Kleinstiver et al. 2016)) will reduce off-target effects. Also the use of orthologous Cas9s (from different 
bacterial species) that require longer PAM-sequences (e.g. -NNAGAAW for Cas9 of Streptococcus 
thermophilus instead of -NGG for Cas9 of Streptococcus pyogenes) results in reduced off-target activity 
(Ran et al. 2015). The search for the system with the least off-target effects is partly driven by potential 
applications in human patients, but plant biotechnology will benefit from these developments as well.  
Application areas 
SSNs without a repair template are mainly used to produce knock-out mutants and have already been 
applied to change oil composition by biochemical pathway engineering in oil crops (in soybean; Haun et 
al. 2014) and to achieve disease resistance by knocking out disease susceptibility (S) genes (in wheat; 
Wang et al. 2014). SSNs have also been used in rice to remove a specific element of an S gene promoter 
to prevent upregulation by pathogen-derived effector molecules, which led to bacterial leaf blight 
resistance while the gene remains functional for vital functions in the plant (Li et al. 2012). These are 
examples of how (novel) traits may be engineered by the removal or deletion of genes or elements, next 
to the insertion of new genes or alleles (which is the main strategy used with SSN (HR), as described in 
section 4.3).  
Barriers and drivers  
One important driver of development in this technology is the discovery of CRISPR-Cas. Other drivers are 
increasing high throughput sequencing potential and advancements in bioinformatics, which promotes 
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the discovery of gene functions, and which are also powerful tools for genome-wide screening of the final 
products for absence of SSN-DNA sequences and potential off-target mutations (Kim et al. 2015). The 
latter requires the availability of reference genome sequences, which are still of insufficient quality for 
most crop species (Feuillet et al. 2011). Barrier is off-target activity (but see above under “Host effects” 
for improvements).  
Interviews confirmed that CRISPR-Cas is expected to expand enormously in the coming years, as it is the 
most easily applicable method of genome editing, also within the reach of small companies with limited 
resources for laboratory facilities. Intellectual property issues could be a barrier: the present legal 
dispute in the US about who can rightfully claim to be patent holder of the technique may create 
uncertainty around its commercial use.  
Horizon  
Currently, CRISPR-Cas is surpassing other SSNs as method of choice, which was confirmed in interviews. 
As reported for ODM, commercial applications will be dependent on decisions about regulatory oversight 
in the EU. Pioneer’s waxy maize developed by CRISPR-Cas was very recently considered not to be 
regulated by USDA-APHIS in the US (https://www.aphis.usda.gov/biotechnology/downloads/reg_loi/15-
352-01_air_response_signed.pdf).  
A recent publication describes the option of avoiding transformation of the plant’s genome, by transient 
expression of SSN genes in protoplasts followed by regeneration and testing for non-integration of the 
SSN construct (Clasen et al. 2015). The “DNA-free” use of CRISPR-Cas9 as preassembled 
ribonucleoprotein, rather than as DNA construct, for inducing DSBs has also recently been described for 
gene targeting in lettuce (Woo et al., 2015). A barrier for these variants is the availability of a protocol 
for regeneration of plants from protoplasts (like in ODM, section 4.1), which is only applicable in a limited 
number of crop species.  
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4.3. Genome editing using sequence-specific nucleases (SSNs): homologous 
recombination (HR) pathway 
 
Technical description 
In an alternative SSN technology, the SSN-induced double-strand break (DSB) is precisely repaired by 
the native homologous recombination (HR) pathway on the basis of a DNA repair template supplied to 
the cell that is (partly) homologous to the target site. Using this homology-driven repair (HDR) approach, 
native gene sequences can be replaced by homologous sequences with small modifications. Also 
completely new DNA sequences can be incorporated at a predefined chromosomal target site. The 
application of SSN technology aimed at HDR is also referred to as gene targeting (GT) (Osakabe and 
Osakabe 2015; Puchta and Fauser, 2013). HDR is a very inefficient process in plants and requires 
selectable markers to effectively recover GT events (Endo and Toki 2014).  
Host effects 
The host effects are dependent on the type of insert and range from changes in gene expression level 
and pattern (in case regulatory elements have been replaced) or changed functionality of native genes to 
complete new gene functions in case novel coding sequences are introduced. As unintended effect, the 
SSN-induced DSB can result in indels instead of gene correction or replacement, or additional indels at 
the same locus in homologous chromosomes in case the NHEJ-repair pathway is activated, which is more 
efficient in plants than the intended HR repair pathway. Similarly as described for genome editing using 
SSNs and NHEJ pathway, potential off-target indels caused by NHEJ-repair of DSBs at off-target sites 
must be taken into account also here.  
Application areas 
There are only a few reports describing the application of HDR for genome editing in plants. In maize and 
soybean (Svitashev et al. 2015; Li et al. 2015) the acetolactate synthase (ALS) gene was targeted using 
CRISPR-Cas9 and modified using a DNA repair template containing several nucleotide changes compared 
to the native sequence, thereby providing chlorsulfuron herbicide resistance. In another example using 
ZFNs and HDR, insertional disruption of the inositol-1,3,4,5,6-pentakisphosphate 2-kinase (IPK1) gene in 
maize was achieved (Shukla et al. 2009). IPK1 catalyses the ﬁnal step in phytate (an anti-nutritional 
component sequestering phosphate in feed grains) biosynthesis in maize. Because the IPK1-gene is 
disrupted by a transgenic phosphinotricin acetyltransferase gene sequence insert (which mediates 
tolerance to the herbicide agent phosphinotricin (glufosinate) and is used for selection of HDR integration 
events), the maize plants with a reduced phytate trait still contain foreign sequences in the end product. 
HDR-mediated gene integration has also been used for sequential stacking genes into a so-called ‘safe 
harbour’ locus, which is a chromosomal location where genes can integrate and function in a predictable 
manner (Ainley et al. 2013). An advantage of gene stacking at a single locus is that during subsequent 
crossings the stacked transgenes segregate as a single locus, which would simplify breeding of plant 
lines with stacked transgenes (Nandy et al. 2015; Srivastava and Thomson 2016). There is a clear 
interest in stacking of transgenes. For example, Monsanto and Dow AgroSciences collaborated in the 
production of maize, cotton and soybean lines in which transgenes have been stacked, and 
commercialized these lines as SmartStax™. The largest combination to date is eight genes coding for HT 
and insect resistances in SmartStax™ maize, which was launched in the USA and Canada in 2010 (James 
2014). These transgenes were stacked by traditional crossing.  
A specific application of SSNs and HR repair described recently uses CRISPR-Cas for a mutagenic chain 
reaction to convert heterozygous mutations to homozygous ones (Gantz & Bier 2015). This system, 
called “gene drive”, generated efficiently homozygous mutations in the malaria vector mosquito 
Anopheles stephensi (Gantz et al. 2015) and to a lesser extent in Drosophila fruit flies (Gantz & Bier 
2015). Effective gene drives require a combination of an efficient HDR mechanism, a short generation 
time and genetic mixing in a population. Because in plants HDR is not efficient and so requires a strong 
positive selection for gene targeting events, CRISPR-Cas-mediated gene drives are as yet not expected 
to be effective in plants.  
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Barriers and drivers 
The use of homologous recombination to precisely modify plant genomes has been challenging, due to 
the lack of efficient HR methods in plants. Current examples of genome editing by HR therefore rely on 
the use of selectable transgenes. Improvements, such as the use of geminivirus replicons for delivery of 
the SSN-coding sequences and the DNA repair template may overcome the efficiency barrier (Čermák et 
al. 2015) and drive genome editing by HR towards commercial applications.  
Horizon 
Precision breeding by allele replacement, replacing poor alleles by beneficial ones, including cisgenic 
applications (see section 4.5), promoter replacements, and stacking transgenes at a single chromosomal 
locus could be interesting future applications. However, commercial applications are not expected in the 
near future as HR is still technically challenging. The interviews indicated that this variant could be seen 
as quite similar to classical plant transformation (cf. EFSA’s analysis of ZFN3 (SDN3, SSN3), EFSA GMO 
Panel 2012b) and therefore, regulatory barriers were envisaged in the EU.  
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4.4. Plant transformation with transgenes not in end product 
 
Technical description 
This category is a container concept rather than a technique, in which “classical” transgenic plant lines 
are being used in various ways to enable more efficient and faster breeding or plant (hybrid) variety 
production, but in which the end products do not contain the transgene any longer. In most cases, it may 
also be referred to as the use of “null segregants” (Camacho et al. 2014). The element of the use of 
transformation without the transgene ending up in the final plant product is actually also applicable in the 
genome editing techniques based on SSNs and a variant of TGS (RdDM), but these techniques are 
discussed in separate sections 4.2-4.3 and 4.7, respectively, because of their specific nature.  
Host effects 
The category covers a wide variety of approaches, which have in common that no transgene is present in 
the final plant products. This concept is mainly applied to facilitate and speed up plant breeding and thus, 
the transgene used for that purpose can or even needs to be removed by subsequent steps of crossing 
and screening for absence of the transgene to achieve an optimal result. Any unintended effects in the 
genome away from the transgene in the transgenic line will be minimal as repeated backcrosses to 
obtain elite material (varieties) are used and thus only a small part of the transgenic line’s genome 
remains present in the final product (see further under section 4.5).  
A special variant is the use of transgenic rootstocks. In this case, products of the scion are free of 
transgenes, but gene expression and (heritable) epigenetic state in the scion may be influenced through 
signalling pathways from the rootstock, e.g. through the transport of small RNAs (see RNAi sections 4.6 
and 4.7). In addition, genetic exchanges have been reported to occur at the graft junction (see last 
Techniques section 4.10).  
Application areas 
There is a wide array of applications in which this strategy may be implemented. Examples are:  
Early flowering: perennial woody crops, such as fruit trees, have long generation times and therefore 
lengthy breeding cycles. This can be sped up using backcrossing schemes involving lines that are early 
flowering by overexpressing exogenous flowering genes, such as BpMADS4 in apple (Flachowsky et al. 
2011) and PtFT1 in Eucalyptus (Klocko et al. 2015) or in plum (Srinivasan et al. 2012), the latter called 
“FasTracking” (Yao 2011). In apple, proof of concept was demonstrated by combining a fire blight 
resistance from a wild relative (Malus fusca) with the new early flowering line followed by further 
crossing with another cultivated line containing additional disease resistances, leading to seedlings 
having all resistances combined within three years (Flachowsky et al. 2011).  
Hybrid seed production: Production of doubled haploid lines that can be used as parents for hybrid seed 
production (and in breeding research, e.g. mapping, Van de Wiel et al. 2010) can be sped up by inducing 
haploids using a parental line with a mutated centromere-specific histone CENH3 (centromere-mediated 
chromosome elimination CCE). When the cenh3 mutant is crossed to another plant, the chromosomes 
from the mutant are selectively lost, leaving a haploid progeny, some of which may turn into fertile 
doubled haploids through irregular non-reduction during meiosis. As this CENH3 mutation is lethal, 
mutant lines can be maintained by introducing a transgenic rescue construct containing a variant of wild 
type CENH3. The chromosome elimination process, which also leads to loss of the transgene in the 
progeny, is thought to occur through unequal interactions with the mitotic spindle at the centromeres 
(Ravi and Chan 2010).  
Hybrid seed production: Pioneer is using a transgenic maintainer line in the propagation of the male-
sterile female parental line in their hybrid production system “SPT”. The transgenic construct encodes a 
protein (MS45) that compensates the mutant version causing the male sterility of the female parent line. 
The transgenic construct is present in a hemizygous state and therefore is inherited in half of the pollen 
produced by the maintainer. The construct also encodes an α–amylase (ZM-AA1) that renders the pollen 
infertile and so only the pollen without the transgenic construct produce offspring that can be used as 
female parent in subsequent hybrid seed production. To ensure that the seeds are completely free of the 
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transgene, the construct contains a third gene coding for a fluorescent marker enabling to check all 
seeds in a non-destructive manner (Wu et al. 2016).  
Hybrid seed production: Rijk Zwaan developed a concept for making homozygous parental lines from a 
superior heterozygous plant by using a transgenic or mutant line silenced in meiosis, called reverse 
breeding (Dirks et al. 2009; Wijnker et al. 2012).  
GM rootstocks can be used for a wide array of applications, such as resistance to soil-borne diseases and 
pests and improved rooting ability.  
Barriers and drivers 
Almost all techniques (except for GM rootstocks) have a common driver in that they increase the speed 
of breeding and/or the efficiency of hybrid seed production.  
Horizon 
Hybrid seed production is being developed or searched for in many crop species. Currently, Pioneer is 
testing the SPT technology in rice and wheat (still in experimental phases (Pioneer 2016)). This is a 
potentially huge market as rice and wheat are still mostly sold as inbred seeds. The interviews confirmed 
that generally, among all methods to accelerate breeding, the ones improving hybrid variety breeding or 
enabling it in crops where this is not yet feasible, are highly interesting for breeders. For instance, 
Pioneer also developed a transgenic hybrid seed production system using transcriptional gene silencing 
(see RNAi – TGS section 4.7). As mentioned under the genome editing techniques, regulatory status 
affects the likelihood of commercialization in the EU. The USDA decided that the F1 hybrid varieties 
produced using such a system are outside the scope of regulation in the US, provided that the transgene 
is absent in all seeds (Camacho et al. 2014).  
Early flowering was recently shown to be achievable using a virus vector containing a construct 
expressing an Arabidopsis Flowering Locus T gene and silencing the Terminal Flowering 1 gene in apple 
(Yamagishi et al. 2014). The virus used is not seed-transmissible; thus, the trait is achieved without 
genetic modification of the apple genome (cf. similar applications in RNAi section 4.7). When the virus is 
applied to cotyledons, the seedling will be induced to flower, so the approach is versatile as for any seed 
in any generation it can be decided to induce early flowering or not. Additional possibilities with grafted 
plants are mentioned under RNAi sections 4.6 and 4.7.  
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4.5. Plant transformation introducing genes from cross-compatible species 
 
Technical description 
The central tenet in this concept is the use of sequences from cross-compatible species (also referred to 
as the primary and secondary gene pool (i.e., varieties and landraces, and wild species, respectively) in 
the context of conventional crossing methods). Two variants are discerned: cisgenesis and intragenesis 
(Holme et al. 2013). Cisgenesis involves transformation with genes from cross-compatible species in 
their native state, i.e. with their own promoters and introns (Jacobsen & Schouten 2007). In addition, 
the use of additional genes for selecting transformants should be avoided or such selection genes should 
be removed by inducible site-specific recombination methods (Schaart et al. 2011). Intragenesis likewise 
involves the use of genes (sequences) from cross-compatible species and marker-free transformation, 
but the gene sequences are recombined with e.g. other promoters or in other orientations, in order to 
achieve novel traits (Rommens et al. 2007).  
Host effects 
With cisgenesis, the normal effects of the genes are expected as when they would be introgressed 
through backcrossing. With intragenesis, the effects depend on the specific construct as with 
transgenesis. An already established variant is represented by constructs silencing specific genes (see 
under RNAi section 4.6). Other possible variants are increasing or ectopic expression of specific genes by 
careful choice of alternative promoters, up to rewiring of developmental pathways. Unintended effects of 
intragenesis will mainly depend on the type of novel trait designed (EFSA GMO Panel 2012a).  
Any possible unintended effect relating to standard plant transformation (e.g. related to random insertion 
of T-DNA into the genome) will be similar for cis- as well as intragenesis (and transgenesis) (cf. EFSA 
GMO Panel 2012a; Parrott et al 2010; Ladics et al. 2015).  
Application areas 
The sort of applications in cisgenesis is limited by definition to native genes or alleles not yet present in 
the targeted elite plant material. Examples published comprise stacking R genes, for instance against 
late blight caused by Phytophthora infestans in potato (Haesaert et al. 2015; Haverkort et al. 2016) or 
against scab caused by Venturia inaequalis in apple (Krens et al. 2015). Possible applications in 
intragenesis may vary widely, including disease resistance, e.g. against Botrytis through combining the 
coding sequence of the strawberry polygalacturonase-inhibiting gene with the fruit-specific promoter 
from the strawberry expansin 2 gene (Krens et al. 2012), and drought tolerance through recombining 
vacuolar pyrophosphatase 1 with an endogenous drought-inducible promoter from dehydrin (Templeton 
et al. 2008, at that time still rated as “cisgenic”). Other examples are gene silencing, e.g. for improving 
product quality/composition, through RNAi (see section 4.6) and “rewiring” a developmental pathway, 
e.g. changing secondary cell wall formation to reduce lignin content (see under Synthetic biology section 
4.8).  
Barriers and drivers 
The driver for cisgenesis was developing concepts that may increase consumer acceptance and simplify 
regulatory oversight as the types of genes used are basically the same as the ones already introgressed 
through traditional breeding methods (see under horizon). In addition, the advantage in comparison to 
classical introgression is the increased speed with which R genes can be stacked so as to diminish the 
possibilities for the pathogen to overcome the plant’s resistance. This is particularly useful for crop 
species with long generation times and/or complex breeding due to heterozygosity, such as fruit trees 
and potato. It also enables maintaining the genetic make-up of successful varieties while adding the 
cisgenic traits, which is not possible by classical breeding as crops such as potato and apple are highly 
outcrossing and alternative systems of hybrid breeding have not yet been (fully) developed. 
Developments in sequencing and bioinformatics lead to an increase in knowledge on gene functions and 
effects of natural (allelic) variation, which could be used in both cis- and intragenesis. A complicating 
factor lies in achieving marker-free transformants, which is a less efficient system. The definition of 
cisgenesis poses a limitation on the types of traits attainable.  
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Horizon 
For cisgenesis, a proof of concept has been delivered for late blight-resistant potato, including a 
resistance management system, using the cultivar Desiree in the so-called DuRPh project in the 
Netherlands (Haverkort et al. 2016). In Belgium, VIB (Vlaams Instituut voor Biotechnologie) is working 
on a version using the cultivar Bintje (VIB 2014), which is intended to be ready in 2018. Simplot’s 
variant of the Innate potato containing a single R gene against late blight was deregulated in the US in 
2015 (https://www.regulations.gov/#!docketDetail;D=APHIS-2014-0076). Interviews indicated that 
cisgenesis is seen as a typical example of a technical concept developed in an attempt to simplify 
regulatory concepts, though useful applications are worth considering in their own right. At the same 
time, commercial applications are thus dependent on regulatory interpretations and consumer 
acceptance, including labelling issues.  
An intragenic application using gene silencing is already cultivated in the US, Simplot’s Innate potato 
(see section 4.6).  
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4.6. RNAi – post-transcriptional gene silencing (PTGS) 
 
Technical description 
The technique uses an existing mechanism of post-transcriptional gene silencing (PTGS) to reduce gene 
expression in a targeted fashion. This is achieved by transformation with a construct containing an 
inverted repeat specific to the gene targeted. RNA transcribed from the construct forms double stranded 
RNA (dsRNA) by folding upon itself leading to a “hairpin”. The hairpin is processed into microRNAs 
(miRNA), 20-21 nucleotides (nt) long, by a Dicer protein, DCL1, which is specific to the PTGS pathway. 
The miRNA, incorporated into a specialized Argonaute protein, AGO1, subsequently directs mRNA 
degradation or its translational repression leading to specific silencing of gene expression. The transgenic 
construct remains present in the final plant product in order to maintain gene silencing (Kamthan et al. 
2015).  
A special application of the method is using transgenic constructs targeted against genes of pests (e.g. 
insects) or pathogens (e.g. viruses or fungi), called “cross-kingdom” RNAi or host-induced gene silencing 
(HIGS) (Han & Luan 2015). In this case, dsRNAs are produced that, upon being taken up by the targeted 
pest or pathogen, are processed into miRNAs that interfere with the expression of essential genes (e.g. 
cytochrome p450 monoxygenase, vacuolar ATPase) of that organism.  
Host effects 
The technique leads to targeted gene silencing; therefore, in principle, a wide variety of traits achievable 
by knock-down mutants can be envisaged. Kamthan et al. (2015) discuss applications in plant 
architecture, fruit quality and shelf life, pathogen and pest resistances, several abiotic stress tolerances 
(e.g drought, salt, temperature), and biofortification. Off-target effects of silencing other genes may be 
possible, but little has been published about this (Senthil-Kumar & Mysore 2011; Casacuberta et al. 
2015). There may also be some overlap with TGS (transcriptional gene silencing, also see section 4.7). 
In some cases, the hairpin RNA could also be processed into 24 nt miRNA (lmiRNA) that enters the DNA 
methylation pathway through loading onto AGO4 (Matzke & Mosher 2014). For Arabidopsis, a NERD 
protein has been described that induces RdDM (RNA-directed DNA methylation) using components of the 
PTGS pathway, including 21 nt siRNAs (Pontier et al. 2012). With RdDM, there is also the possibility of 
DNA methylation spreading into sequences adjacent to the RNAi target sequence (Casacuberta et al. 
2015).  
With the “cross-kingdom” RNAi, the range of organisms (e.g. insect species) targeted can be limited by 
careful choosing the gene sequence at which the dsRNA is directed (Burand & Hunter 2013). Whether 
non-target organisms (NTOs) will be affected, will depend on the extent to which specific gene sequences 
can be selected, which in turn will also depend on genome knowledge of (related) species (e.g. insect 
groups) and thus on developments in genomics and bioinformatics.  
Application areas 
“Classical” examples of genetic modification through plant transformation likely employed some way of 
PTGS, such as the FlavrSavr long shelf life tomato and low amylose potatoes (Krieger et al. 2008; De 
Vetten et al. 2003). Recently, a potato with improved product quality, i.e. low in bruise spot and heat-
induced acrylamide formation (Simplot’s Innate potato), and an apple with reduced browning 
(Okanagan’s Arctic apples), both based on the system described in this section, i.e. by introducing 
inverted repeats, were deregulated in the US (Ye et al. 2010; USDA-APHIS).  
Examples of applying “cross-kingdom” RNAi can be found particularly for insects, but also for fungi 
(Fusarium, Cheng et al. 2015) and oomycetes (Phytophthora, Sanju et al. 2015; Bremia, Govindarajulu 
et al. 2015). siRNAs can be transported through the phloem, which opens up the possibility of using 
grafted plants, for example a transgenic rootstock promoting silencing of a target gene in the scion. Zhao 
& Song (2014) showed that siRNAs produced from a transgenic hairpin construct based on the virus 
PNRSV in a sweet cherry rootstock were transported to the scion, which was accompanied by enhanced 
resistance to the virus. An alternative method of delivery of RNAi could become using an attenuated virus 
containing the dsRNA construct (Burand & Hunter 2013).  
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Barriers and drivers 
A basic problem for PTGS can be the efficiency of gene silencing, which will usually be not 100%; at the 
same time, this could be advantageous for traits where diminished expression rather than complete 
knocking-out as in mutants is desirable. The effectiveness of “cross-kingdom” RNAi will also depend on 
the efficiency of uptake by the pest or pathogen, the specifics of the RNAi pathways in the organism, and 
the lethality of the process disturbed. For instance, RNAi appears to work not very well in flies (Diptera), 
which may be related to differences in the Dicer protein or the lack of other factors (Sid-1, Shreve et al. 
2013). A recent improvement in effectiveness was achieved by expression in plastids (Colorado beetle: 
Zhang et al. 2015, Helicoverpa armigera: Jin et al. 2015). The advantage of expression in the chloroplast 
is that the dsRNA is not already processed into siRNAs in the plant host and so is delivered more 
effectively to the targeted insect. Transformation of chloroplasts has also been proposed as a way to 
mitigate pollen-mediated gene flow as plastids are usually transmitted through the mother line in 
Angiosperms (but this is not complete and varies somewhat between species, Stewart & Prakash 1998). 
With regards to applications in other insects, RNAi may not be able to compete with effective alternatives 
already offered by Bt (Bacillus thuringiensis toxin, a bacterial crystalline (Cry) protein introduced using 
“classical” plant transformation) against lepidopterans (moths). However, it may be attractive for control 
of groups for which no effective Bt is available, such as sucking insects, e.g. phloem-feeding aphids 
(Burand & Hunter 2013), though Bt adapted to such groups are being developed (Chougule et al. 2013). 
RNAi may also be helpful for pest insects such as Western corn rootworm that has relatively quickly 
developed resistance to Bt (Baum & Roberts 2014; Lombardo et al. 2016). Finally, there is an alternative 
delivery method for RNAi, i.e. applying it directly by topical application (as spray) (e.g. against virus, 
Robinson et al. 2014) and it will depend on relative efficiencies which method will be most competitive 
(see further Modifying gene expression with exogenous compounds, section 4.9).  
With the fast developments in bioinformatics and DNA sequencing, knowledge is generated that can be 
used to improve the effectiveness and the specificity of “cross kingdom” RNAi. Particularly, recent work 
on (long) non-coding RNAs has contributed to the knowledge on the role of ncRNA in various pathways of 
gene regulation (Ariel et al. 2015; Liu et al. 2015) (see further section 4.7).  
Horizon 
Simplot’s intragenic RNAi-based Innate potato is cultivated in the US (160 ha in 2015) and has just 
received regulatory approval in Canada. Likewise, Okanagan’s Arctic apples have been deregulated in the 
US. BASF’s Amflora “antisense” transgenic construct-based low amylose potato had been authorised in 
the EU for cultivation but was withdrawn shortly before commercialization (BASF 2012). Afterwards, the 
original EC’s decision to authorise Amflora was annulled by the general Court of the EU (Case T-240-10, 
http://curia.europa.eu/jcms/upload/docs/application/pdf/2013-12/cp130160en.pdf). A Monsanto version 
of “cross-kingdom RNAi” against Western corn rootworm, combined with Bt against the same organism, 
has been recently authorised for cultivation in the US and Canada (Lombardo et al. 2015). Interviews 
indicated that the regulatory situation in the EU may as of yet not be favourable to investing in this type 
of work as these all are “classical” GM plants, i.e. containing transgenes. Thus, using topical applications 
(sprays) could be an interesting alternative (but see section 4.9).  
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4.7. RNAi – transcriptional gene silencing (TGS) 
 
Technical description 
The technique uses an existing mechanism of transcriptional gene silencing (TGS), RNA dependent DNA 
methylation (RdDM), to reduce gene expression in a heritable fashion. This can be achieved by 
transformation with a construct containing an inverted repeat specific to the gene (promoter) targeted. 
RNA transcribed from the construct forms double stranded RNA (dsRNA) by folding upon itself leading to 
“hairpins”. This dsRNA is processed into small interfering RNAs (siRNA), 24 nucleotides (nt) long, by a 
Dicer protein specific to the RdDM pathway, DCL3. The siRNA, incorporated into a specialized Argonaute 
protein, AGO4, subsequently directs DNA methylation of the targeted promoter sequence leading to 
silencing of gene expression. Uniquely for higher plants, special DNA polymerases are involved in the 
RdDM pathway, Pol IV and Pol V, which are related to Pol II that is responsible for mRNA production 
(Matzke & Mosher 2014; Ariel et al. 2015).  
The transgenic construct may be removed from the final plant product, e.g. by crossing. An alternative 
tool is using a virus vector to introduce the siRNA (Kasai & Kanazawa 2013). When the virus used is not 
seed-transmissible, the final plant product will remain free of introduced DNA sequences.  
Host effects 
The technique leads to targeted gene silencing; therefore, in principle, a wide variety of traits achievable 
by knock-down epimutants could be envisaged. As in PTGS (see section 4.6), off-target effects may be 
possible, i.e. silencing of genes showing homology in their promoters to the siRNAs produced by the 
constructs used. In addition, in absence of the transgenic RNAi-construct, DNA methylation is expected 
to be lost after some generations of multiplication. In the RNAi – PTGS section 4.6, already overlaps with 
the TGS pathway were discussed. Kasai & Kanazawa (2013) describe a special case with the use of a 
virus vector where TGS involving siRNAs is accompanied by suppression of the PTGS mRNA degradation 
pathway. If the transgenic construct is permanently present in the final plant product (as in RNAi – PTGS 
section 4.6) the effect is expected to be more stable.  
Application areas 
Among the examples mentioned by Kasai & Kanazawa (2013) are reduced flower pigmentation, male 
sterility and reduced amylose content.  
siRNAs can also be subject to long distance transport through phloem, which opens up the possibility of 
using grafted plants, for example a transgenic scion promoting silencing of a target gene in the 
rootstock. Regenerating plants from such a rootstock could lead to an epimutant completely free of 
exogenous DNA sequences (Kasai & Harada 2015). Gene silencing through long distance transmission 
was even achieved by agro-infiltration in the scions (Kasai & Kanazawa 2013).  
There are also reports on mutants of the MSH1 gene showing large changes in DNA methylation patterns 
that are heritable, transmissible between graft partners and that lead to increased growth vigour in 
Arabidopsis (Virdi et al. 2015) and tomato (Yang et al. 2015). It is not yet clear to what extent this will 
lead to applications in breeding.  
An example of using the technique without removing the transgenic construct is a hybrid seed production 
system in maize using the Ms45 nuclear male fertility gene, which in a homozygous recessive (silenced) 
state leads to male sterility. The male-sterile female parental line is created by crossing two 
complementary male fertile lines, each containing the (fertility) Ms45 allele, but with different promoters 
and different RNAi silencing constructs as follows: one line combining Ms45 with a heterologous (active) 
promoter and an RNAi construct silencing the heterologous promoter of the other line and vice versa. 
Thus, the progeny of this cross contains two Ms45 alleles, the promoters of which are each silenced by 
the inverted repeat carried by the other allele, leading to male-sterile plants that can be used as female 
parent in hybrid seed production (Cigan et al. 2014).  
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Barriers and drivers 
A basic problem for TGS is the efficiency of gene silencing, which may vary to an as yet unknown extent 
among genes, and the stability of the TGS in the absence of the inducing construct. DNA methylation is 
maintained by factors such as methyltransferases, e.g. MET1, but can also be removed by factors such 
as DNA glycosylases, e.g. ROS1. Kasai & Kanazawa (2013) showed a higher effectiveness of using a 
virus vector, cucumber mosaic virus (CMV), as vector for RNAi constructs. Disadvantages of such an 
approach are the limitation to particular hosts by the specificity of particular viruses and to seed-
propagated plants.  
With the recent developments in bioinformatics and sequencing, in particular transcriptomics (RNA 
sequencing), knowledge on non-coding RNAs (ncRNA) is expanding quickly (Liu et al. 2015), including 
the development of databases for ncRNAs (Xuan et al. 2015, Patra et al. 2014). This may become a 
driver of RNAi-based methods, as there is still much unknown about mechanisms of RNA-based signalling 
pathways and control of development in plants, in which also histone modifications play a role (Matzke & 
Mosher 2014). At the same time, examples in phosphate homeostasis (Liu et al. 2015) and flowering 
control (vernalization, Chekanova 2015) indicate a high complexity of regulation, which may hamper 
relatively simple applications such as those targeting single genes. In addition, alternative pathways of 
RNAi TGS have been described for Arabidopsis (Bond & Baulcombe 2015). Genome editing techniques, in 
particular CRISPR-Cas (see section 4.2), have begun to be used for testing functionality of ncRNAs 
(Basak & Nithin 2015).  
Horizon 
Interviews indicated that product stability is adamant to breeders’ commercialization decisions (cf. the S 
for stability in the DUS prerequisites for plant variety registration) and this is not clear for RNAi systems 
using DNA methylation in which the transgenic construct has been removed. In addition, there is the 
uncertainty around the status of “null segregants” (see section 4.4) with regard to EU GM regulation. By 
maintaining the transgenic transcriptional silencing construct as in RNAi – PTGS (section 4.6), more 
stable applications are possible, such as a female inbred maintaining system for hybrid seed production, 
but this has the regulatory disadvantage for classical transgenesis already mentioned in the same section 
4.6.  
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4.8. Synthetic biology  
 
Technical description 
“Synthetic biology” does not appear to be a well-defined field, as different authors use it for different 
types of approaches. For instance, genome editing techniques, such as CRISPR-Cas, sometimes are 
included, but in our classification we reserved this term for various alternative, novel uses of the CRISPR-
Cas protein, such as changing it into genome site-specific activators/repressors of gene transcription. 
Definitions of the term entail engineering plants for new functions or devices (e.g. sensors) (Liu and 
Stewart 2015) that are not found in nature, in other words, intentional design of artificial biological 
systems (Lusser et al. 2011). The field is still in its infancy and therefore we will limit ourselves to a few 
examples. The furthest developed branch appears to be the introduction of novel (metabolic) pathways. 
Further away, there is the construction of synthetic chromosomes still in the research phase (Birchler 
2015) that will be briefly mentioned here.  
Host effects 
Introducing novel pathways means changes in (relative) amounts of metabolites or proteins or the 
introduction of products totally new to the plant, such as pharmaceuticals. Effects will depend on the kind 
of pathway introduced and the way of regulating its expression.  
Novel pathways could be systematically introduced through synthetic chromosomes. Minichromosomes 
have been engineered by truncating a B chromosome in maize and adding a transgenic array capped 
with a telomere at one end to the remaining centromere of the B chromosome. For enabling the later 
addition of novel sequences, a sequence for site-specific recombination could be inserted (Birchler 2015).  
The CRISPR-Cas system that is presently widely used for genome editing (see section 4.2), originally 
functions in controlling viruses (bacteriophages) in archaea and bacteria. Ali et al. (2015) reported that 
CRISPR-Cas9 can also be targeted in that manner in plants by overexpressing Cas9 and providing 
guiding RNA (sgRNAs) specific to virus, in this case TYLCV. Virus DNA accumulation was shown to be 
significantly reduced; the system could be extended to other viruses by introducing adapted sgRNAs.  
The specific DNA sequence recognition function of the Cas protein may also be used for other purposes 
than genome editing. By knocking out the DNA nuclease function (dCas9) and combining with alternative 
active domains affecting transcription, the Cas/guide RNA complex can be used as artificial transcription 
factor to enhance or decrease gene expression, or to make it inducible upon demand, e.g. in response to 
the addition of a particular chemical compound. Finally, a complex can be engineered to modify DNA 
epigenetically (e.g. by adding DNA methylating activity, see RNAi-TGS section 4.7, to the dCas9) in order 
to alter gene expression genome-wide (Puchta 2016; Thakore et al. 2016). Very recently, Komor et al. 
(2016) added another variant, i.e. combining dCas with a cytidine deaminase enabling to change a single 
cytidine to uridine (thereby effecting a C to T substitution) without making a dsDNA break (in effect a 
specialized form of genome editing, see section 4.2).  
Application areas 
The classic example of adding a pathway for biofortification is the Golden Rice with increased levels of 
pro-vitamin A, which in its improved version has a transgenic construct of a phytoene synthase from 
daffodil combined with the originally used carotene desaturase from Erwinia uredovora (Paine et al. 
2005). More extensive adaptation of pathways for biofortification has been described for maize by Zhu et 
al. (2008) and Naqvi et al. (2009; 2011). They used combinatorial transformation to enhance vitamin 
production in endosperm, which meant introducing 5 transgenic constructs, including various 
endosperm-specific promoters, simultaneously through a biolistics approach followed by selecting plants 
expressing several or the complete set of transgenes for their production efficiency. In this way, Zhu et 
al. (2008) increased vitamin A (carotenoid) production and Naqvi et al. (2009) increased production of 
even three vitamins at the same time: β-carotene, ascorbate and folate.  
An example that could count as a special application of intragenesis (see section 4.5) is the “rewiring” of 
a developmental pathway, e.g. changing secondary cell wall formation to reduce lignin content and 
increase polysaccharides for biofuel production (Yang et al. 2013). Lignin deposition was directed to 
29 
 
vessels by placing the cinnamoyl CoA 4-ligase (C4L) gene under the pVND6 promoter in an Arabidopsis 
c4l mutant in order to keep vessel formation (and thus water transport) effective while fibres remained 
low in lignin and at the same time had a higher cell wall polysaccharide deposition by the introduction of 
an artificial positive feedback loop using the master fibre transcription factor NST1.  
In the border area between “white” and “green” biotechnology, already for some time the possibilities of 
using plant (cells) for the production of high value compounds, in particular pharmaceuticals, is being 
studied. For instance, monoclonal antibodies can be produced in plants. In addition, antigens for use as 
vaccines can also be produced in plants and thus, could also be applied orally (recent review: Juarez et 
al. 2016).  
Barriers and drivers 
For pharmaceutical purposes, technical hurdles had to be overcome, such as adjusting protein 
glycosylation patterns to mammalian (human) patterns. Even though there may be clear advantages to 
using plants for pharmaceutical production (cost effectiveness, safety as they will be largely free of 
human pathogens, often more simple purification), it appears to be difficult to compete with existing 
production systems (Juarez et al. 2016). Moreover, the potential admixture of therapeutic production 
systems with food production in the same crop, particularly in plant species with seeds attractive for 
pharmaceutical production purposes, such as maize, will call for tight containment schemes (e.g. Mascia 
& Flavell 2004). Alternative uses of CRISPR-Cas and synthetic chromosomes still appear to be in the 
research phase.  
Horizon 
Of metabolic pathways for biofortification, Golden Rice is still in the phase of multi-location field trials for 
optimizing yields (IRRI 2014). Up to now, the only therapeutic that has been approved (by the FDA in 
the US) is a human enzyme, taliglucerase α, for the rare lysosomal storage disorder, Gaucher disease, 
produced in carrot cells by the Israelian company Protalix. The interviews indicated that, partly 
depending of what one counts as synthetic biology, most of it is too far away from practical applications 
and/or showing unclarities about the position in safety assessments/regulation to be fit for applications. 
Engineering metabolic pathways and/or production of pharmaceuticals could be interesting, provided that 
the production can be strictly contained, particularly with regard to crops species also used in food 
production. Thus, measures to avoid gene flow or any other admixture between a pharmaceutical line 
and the conspecific food crop need to be in place. Other interesting applications are in the field of bio-
economy, e.g. low lignin (see the “rewiring” Arabidopsis biofuel example above under “Application 
areas”, also “classical” transgenic examples in poplar have been tested in the field, cf. Van Acker et al. 
2014).  
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4.9. Modifying gene expression with exogenous compounds 
 
This is a category outside of the central theme of this study, i.e. modifying gene expression in a heritable 
fashion, but because of overlap with developments described above it will briefly be touched upon here.  
Implementing RNAi against pathogens and pests (see RNAi-PTGS section 4.6) may take the form of 
topical application of dsRNA solutions (e.g. against virus, Robinson et al. 2014; against insects, Baum & 
Roberts 2014). Their effectiveness depends on the development of formulations with delivery agents that 
improve delivery to the pathogen or pests and environmental stability (Baum & Roberts 2014). Efficient 
delivery solutions may also be used to direct gene expression in plants, for instance to improve shelf life 
or to induce drought tolerance during a period of water deficit (for review, Hu & Lübberstedt 2015).  
A special variant of such crop management by spraying is by engineering ABA receptors to be responsive 
to specific agrochemicals, so that ABA signalling can be activated by spraying an agrochemical during 
drought spells (Rodriguez & Lozano-Juste 2015).  
Agro-infiltration, including use of virus vectors, is still mainly used for research purposes. It can also be 
used for high value protein production (see Synthetic biology, section 4.8). Special variants, early 
flowering induced by using a virus vector and TGS in rootstocks by agro-infiltration in the scion, are 
discussed above (Plant transformation with transgenes not in end products section 4.4 and RNAi-TGS 
section 4.7, respectively).  
“DNA-free” genome editing through SSN delivery as protein or transient expression in cells is discussed 
above under Genome editing section 4.2.  
Interviews indicated that for many breeders sprays are outside of their business models, but it could be 
interesting for growers to increase flexibility and yields, and to simplify the choice for a particular variety 
to grow, which normally often involves uncertainties about expected water conditions and pest/pathogen 
levels. Regulatory aspects have been discussed above under RNAi – PTGS section 4.6.  
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4.10. Regenerating a species hybrid from a graft junction 
 
In 2009, Stegemann & Bock reported that they were able to regenerate shoots from cells in tobacco graft 
junctions in which the cytoplasmic (plastid) genomes and nuclear genomes of scion and rootstock were 
exchanged. They used different transgenic antibiotic resistances and fluorescent reporter genes to select 
for and confirm these new combinations of plant genetic materials. These new combinations are like 
plant products that can be obtained by cell fusion (somatic hybridization), which is an established 
technique mainly used for introducing CMS (cytoplasmic male sterility) in crop plants (Van de Wiel et al. 
2010). However, in this case it is not clear by what mechanism cytoplasmic and nuclear genomes 
become exchanged. In a next step, Fuentes et al. (2014) showed that they could also regenerate a new 
allopolyploid species hybrid from a graft junction between Nicotiana tabacum and N. glauca. Here the 
new combinations of the two nuclear genomes were again selected by using different transgenic 
antibiotic resistance and reporter genes. Apart from the use of transgenic selection markers, the 
techniques used here appear to be in the realm of conventional breeding: grafting and plant regeneration 
through tissue culture. Nevertheless, these intriguing observations may open up a novel way to generate 
difficult species hybrids. As these are as of yet single research examples, it is not yet clear to what 
extent this method may lead to commercial applications in breeding.  
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5. Discussion and conclusions 
The aim of this study was to provide an overview of new developments in plant biotechnology. These 
encompass both novel techniques such as genome editing and new concepts or applications for already 
established techniques such as plant transformation (transgenic plants). We performed a literature 
review and held interviews with stakeholders. The interviews followed the list of techniques presented 
above (cf. Table 1 and Annex) and their results were mentioned with each technique discussed, mostly in 
the Horizon paragraphs. The interviews were especially helpful in identifying drivers and barriers 
(particularly those perceived with regard to regulatory uncertainty) and the (short term) horizon of 
products of the techniques. They generally confirmed that we had not missed relevant developments. 
Nevertheless, one needs to take into account that companies basically may not be able to freely discuss 
every novelty as they may feel the commercial need of protecting their business strategy.  
We will first discuss the classification of techniques that we followed here. Subsequently, we will discuss 
intended and unintended effects of the techniques, followed by drivers and barriers for their application, 
and finally the horizon, i.e. what kind of applications can be expected in the short and medium term.  
Classification 
We presented our overview of developments in plant biotechnology by a listing of techniques and/or 
concepts as follows (see Table 1): genome editing, alternative uses of classical transformation 
technology, RNAi (specific gene silencing) methods and synthetic biology, plus remaining categories of 
external compounds directing gene expression and an additional development in grafted plants. There 
are, however, many cross-connections among techniques and concepts. Thus, not only “Plant 
transformation with transgenes not in end product” but actually the greater part of these techniques 
have as common denominator a step involving transgenic lines, with the transgene not being part of the 
final plant product. Only the genome editing variant SSN - HR (with foreign sequences), 
cisgenesis/intragenesis and RNAi-PTGS (and some applications of RNAi-TGS) rely on the presence of the 
introduced sequence or transgene in the final plant product. In an attempt to visualize cross-connections, 
an alternative scheme shown in Table 2 presents the developments according to the way transgenic 
constructs are used: plants with transgene insertion(s), with transgene insertion followed by removal, 
and transient expression/presence or even not using any (transgenic) DNA but (ribo)proteins of RNA for 
changing traits. This scheme further shows that there are multiple ways of implementing genome editing 
technology, including alternative forms of CRISPR-Cas, and of using RNAi, and the use of virus vectors as 
alternative to “classical” transformation. “Classical” use of transformation (with the transgene(s) in the 
final plant product) also shows further developments with novel traits, such as introduction of metabolic 
pathways involving larger numbers of (recombined) genes, but these may not be immediately obvious as 
category, as we classified this more or less arbitrarily with Synthetic biology (apart from the special 
cases of cis/intragenesis). Classification could also be based on the nature of the final plant products, 
such as plants with new genes at a new chromosomal locus, plants without new genes but with a 
mutation and plants without new genes or new modifications, which was used in Schaart et al. (2016).  
A special case is the use of grafted plants. We included the use of a transgenic rootstock under “Plant 
transformation with transgenes not in end product”, whereas for instance, Lusser et al. (2012) had a 
separate category for it. Grafting is indeed special in that part of the plant cultivated contains the 
transgene, in the particular example the rootstock, and so the harvests from the scion, do not. On the 
other hand, apart from providing resistance to soil-borne diseases, such grafted plants can also be used 
in both forms of RNAi (PTGS and TGS) by providing transportable siRNA that can influence gene 
expression in the scion, up to a variant where a TGS plant without transgene is regenerated from a 
rootstock silenced by RNA from a transgenic or infiltrated scion. Such links between uses of the 
technologies are also referred to as much as possible in the individual sections of chapter 4.  
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Intended and unintended effects 
As in classical plant transformation, intended and unintended effects will largely depend on the type of 
novel trait introduced and so will vary from case to case. Genome editing and RNAi techniques, and 
potentially synthetic biology, enable changing a wide variety of traits, e.g. abiotic stress tolerances, 
disease resistances or metabolic changes underlying product quality. With genome editing (except for 
SSN – HR using “foreign” sequences as template) and RNAi, existing (“native”) plant genes are changed. 
ODM can produce gene knock-outs and small changes of one amino acid. SSN – NHEJ will mainly 
produce gene knock-outs. Thus, with SSN – NHEJ mainly recessively inherited traits will be produced, 
while with ODM additionally (co)dominantly inherited traits may be possible, that is, those based on 
single amino acid changes. SSN – HR enables producing precise changes, from small sequence changes 
up to inserting complete (novel) gene sequences, and thus dominantly inherited traits (allelic variants or 
novel genes). With RNAi, gene knock-downs are produced, but as opposed to genome editing, they will 
inherit dominantly, as long as the silencing construct is present in the plant line. With “null segregants”, 
such as in early flowering, a large array of traits can be introduced, but in this case, apart from using the 
transgenic line for improving efficiency, conventional crossing methods are used, and so both recessively 
and dominantly inherited traits may be produced based on existing genes in the cross-compatible 
germplasm.  
Interesting examples of effects directly related to a specific trait are found in resistances to insects or 
pathogens. One of the recent trends is knocking out/silencing so-called S (susceptibility) genes (Pavan et 
al. 2010). This could lead to unintended effects, i.e. changes in plant performance and/or affecting non-
target organisms (NTOs). An intriguing example of avoiding the first is using genome editing for making 
a small change in the promoter of an S gene in rice abolishing the target of a bacterial pathogen without 
affecting the promoter regions used for the gene’s expression necessary for plant performance (Li et al. 
2012).  
Resistance to insects or pathogens through “cross-kingdom” RNAi or host-induced gene silencing (HIGS, 
a special application of PTGS) is another interesting trend and may represent a case of a truly “novel” 
type of trait, though exchange of small RNAs between organisms is an existing phenomenon (cf. Han & 
Luan 2015). This trait is based on a transgenic construct maintained in the final plant product. The 
transgenic construct introduced encodes a dsRNA targeted at vital functions of the pest or pathogen. By 
carefully choosing the gene sequences targeted in the pest insect, effects on non-target organisms 
(NTOs) could be minimized to an even larger extent than with Bt. The occurrence and magnitude of side-
effects will depend on the possibilities of identifying suitable target sequences that are specific for the 
target organism only. It can be expected that increased availability of genome sequences will increase 
the ability to find such sequences, and if genome sequences are not available yet, it has become cheaper 
and easier to produce them for the purpose of such a project.  
As the greater part of these techniques uses the transgene during the process but not in the final (plant) 
product, unintended effects from the transgenes are lacking, and any effect from the transformation 
process on the genome of the transgenic line will be minimal as most of its genome will be removed by 
repeated backcrossings during the breeding process towards varieties. For SSN-based genome editing 
techniques there is even an alternative to avoid transformation altogether, employing transient 
expression of the construct encoding the SSN in the cell and regenerating plants lacking transgenic 
insertions in their genome. A step further in this direction is introducing the proteins and/or gRNAs 
directly into protoplasts (DNA-free genome editing). For the “null segregant” approaches, such concepts 
are also explored, for instance in early flowering. An interesting variant published for early flowering is 
introducing expression constructs through virus vectors, which are subsequently removed, e.g. in case 
the virus is not seed-transmissible, so will not end up in the progeny. Examples of using virus vectors are 
also reported for genome editing and RNAi (see Table 2). Notably, for many of the “null segregant” 
approaches, removing the transgene is inherent to effective usage of the technique, so not primarily 
aimed at any unintended side effects. For example, the transgenic early flowering trait is useful during 
the (back)crossing process but is unwanted in the end product.  
HR (homologous recombination) application of SSNs could provide a more precise way of introducing 
desirable alleles, e.g. by exchanging them with alleles present in the elite material. In this way, 
(cis)genes could also be introduced at precise locations in the genome in order to reduce unintended 
effects to the minimum. Further development of NGS and bioinformatics will provide clues to desirable 
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alleles or cisgenes by allele mining/modelling, for instance in wild/exotic plant accessions. HR is however 
still technically difficult and having off-target effects for which solutions are being researched.  
Depending on the specific variant, off-target mutations (unintended modifications at other chromosomal 
locations) are possible with genome editing. For CRISPR-Cas9, in the highly active field of medical-
biological research, improvements have been made to the Cas9 protein or gRNA in order to reduce the 
off-target effects. In addition, such effects could now be identified (to some extent) using NGS and 
bioinformatics (genome re-sequencing) (see e.g. Kim et al. 2015). One needs to place this in the context 
that genome editing is expected to be far more precise than classical mutagenesis (which also induces 
multiple random mutations that are not related to the trait of interest), and that plant breeding involves 
extensive phenotypic and increasingly genotypic testing for selecting elite materials for commercialization 
(for instance, removing unintended phenotypes from materials generated by classical mutagenesis, cf. 
EFSA GMO Panel 2012a).  
Likewise with RNAi, though aimed at specific gene sequences, off-target silencing also appears to be 
possible, but relatively little has been reported about it. NGS and bioinformatics (transcriptome 
sequencing) could be helpful in assessments here as well. It might be complex however to take into 
account all potential variability in a crop species, as small sequence changes already will have effects 
with the short sequences (21-24 nt) used in RNAi. An alternative approach could be to compare intended 
and unintended target mRNAs from the plant with the RNAi construct and an isogenic line in sequence 
libraries of RNAi-cleaved mRNA made using PARE (parallel analysis of RNA ends) (Casacuberta et al. 
2015). The recently increased attention to ncRNAs in fundamental research may be helpful (e.g. Liu et 
al. 2015), also in gaining more knowledge on RNAi mechanisms and the various pathways leading to 
PTGS and/or TGS.  
Drivers and barriers 
An important general driver for many of the new developments is the search for concepts that may 
simplify compliance with regulatory demands or that may be outside of regulatory oversight. At the same 
time, as long as the status of techniques with regard to regulatory oversight in the EU is not clear, they 
are not likely to be applied directly for producing marketable products. Cisgenesis is a case in point: the 
use of genes in their native state from the crop and related species themselves was expected to simplify 
regulatory assessment of the plant products and to improve consumer acceptance. Subsequently, a proof 
of concept was delivered, e.g. in late blight resistant potato (Haverkort et al. 2016), but commercial 
application has not yet taken off in view of the unclear regulatory status. As long as the legal situation is 
regarded as complex or costly, it may even be the case that breeders use all available novel technology 
plus “big data” (sequencing technology and bioinformatics) in their research (leads, traits), but for 
commercial application subsequently “reconstruct” the promising plants using conventional means, such 
as mutagenesis. For example, one could test mutations in various genes using CRISPR-Cas9, identify a 
mutation in a gene that has the desired phenotypic effect, then search such a mutation in a population 
generated by mutagenesis using powerful new DNA sequencing methods for efficient screening. The 
mutated allele is subsequently used in the normal breeding program.  
The large progress in sequencing (NGS, RNA seq) and bioinformatics has already been mentioned and is 
generally an important background driver for many of the new techniques. Data produced using these 
techniques may provide clues for genes to be targeted by the genome editing techniques, while in turn 
these techniques, particularly CRISPR-Cas9, can serve as a powerful tool for functional genomics, i.e. to 
test for the functions of genes/alleles or ncRNAs (Basak & Nithin 2015). NGS and bioinformatics also 
provide wider knowledge on RNAi pathways, possibly also for methods such as TGS (RdDM) for which the 
expected stability of the plant product (i.e. the DNA methylation) hampers commercial application in the 
case that the transgenic construct is removed from the final plant product. In addition, an upcoming field 
is the finding of the common occurrence of long non-coding RNAs in the genome, including various 
examples of how they could be involved in regulating gene expression. For instance, various lncRNAs 
transcribed from the flowering gene FLC in Arabidopsis were shown to be involved in regulating 
vernalization (Chekanova 2015). This field is in its infancy and practical applications have not yet been 
identified.  
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Horizon 
Table 3 presents an overview of the techniques with the horizon of applications. In some areas, 
developments are going fast, particularly in genome editing. For the ODM variant, the HT oilseed rape 
(SU canola) developed by Cibus has been brought to the market in the US and was recently authorised in 
Canada. In the SSNs, variants are quickly following upon one another, with the most striking 
development being CRISPR-Cas9. This technique was not even mentioned in the review of novel plant 
breeding techniques by Lusser et al. in 2012, but is now most promising due to its relatively easy 
applicability for a wide array of possible traits. The main focus of the genome editing techniques is 
introducing targeted changes in the genome, which is an improvement compared to random changes in 
classical mutagenesis. This even enables inducing changes that would be unlikely to be achieved by 
traditional mutagenesis (see the example of an S gene in rice above under “Intended and unintended 
effects”).  
Another interesting development is the use of “null segregants”, i.e. the use of transgenic plants at some 
stage in breeding or seed production, but the final product does not contain the transgene. These are 
used for speeding up the breeding process, e.g. in early flowering in crop species with long generation 
times such as fruit trees, or for implementing a particular step in the process, such as haploid inducers. 
An example of early flowering is the FasTracking system in plum. An example in hybrid seed production, 
Pioneer’s SPT system using a transgenic maintainer line, is already applied in the US.  
RNAi applications range from a product quality example in potato already cultivated in the US (Simplot’s 
Innate potato) to interesting developments in disease and pest resistance for which one example against 
insects was recently authorised in the US (against Western corn rootworm in maize). TGS in the form of 
RdDM (with removal of the transgenic construct) is unlikely to be effective in the short term for lack of 
trait stability.  
Whether synthetic biology is far away from applications partly depends on how it is defined. Engineering 
metabolic pathways is already developing for some time following various concepts: introducing a series 
of transgenes encoding several vitamin pathways for biofortification, or even rewiring pathways by 
rearranging genes and promoters within the intragenesis concept. A high-value example is the 
production of pharmaceuticals for which plants have advantages as providing clean products relatively 
cheaply (e.g. free of human pathogens). Glycosylation patterns have been adapted to 
mammalian/human requirements through extensive research. There is only one product authorised at 
present, against an orphan disease (Gaucher). Finally, engineered Cas9 without nuclease activity (dCas9) 
can be used to build novel transcription factors or epigenetic modifiers (Puchta 2016). Whether this 
remains a research tool or will be used in transgenic commercial applications, remains to be seen.  
Generally, the products of the techniques presented in this report need to cross the usual “valley of 
death” for innovations to achieve a commercially viable application. This can range from technical or 
practical barriers with the specific crop or trait to competition with all sorts of alternative approaches. 
Concrete examples have been discussed for engineered metabolic pathways e.g. the biofortified Golden 
Rice still being optimized for agronomical performance and pharmaceuticals in plants. Apparently, 
pharmaceutical plant production systems still can hardly compete with established animal or microbial 
cell systems and there is the added need for careful segregation in the case of using food crops (Juarez 
et al. 2016). As another example, RNAi can be developed for taxonomically diverse groups, but in groups 
where there is a sustainable Bt alternative, RNAi may not be competitive with regard to effectiveness, 
although it could be useful in combination with Bt to mitigate resistance development in the pest insect. 
There may be limitations in getting the dsRNA at the right place in the insect and here an alternative 
may be to use sprays (Baum & Roberts 2014). For this reason, sprays affecting gene expression are 
briefly described in this report. Sprays are further outside the scope when they are not changing 
genomes, and actually belong to the field of pesticides. Furthermore, silencing using RNAi will often not 
be absolute, which may hamper the application for certain purposes, but may be desirable for other 
traits where complete knocking out has undesirable side effects.  
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Conclusions 
Predictions on developments in green biotechnology need to be considered with care as shown by the 
recent overwhelming success of CRISPR-Cas, which was unknown as a genome editing tool in plants just 
five years ago. As already seen in classical GM (transgenic plants), highly promising applications need to 
go through the often painstaking process of achieving commercial viability, i.e. making it into elite 
varieties that are competitive or superior to existing varieties. A practical problem with predicting the 
likelihood of development into commercial products is the additional focus on their regulation. GM 
regulation and labelling are perceived as prohibitively costly and the regulatory process as extremely 
uncertain (in the EU). These regulatory aspects were connected to ideas about consumer acceptance; 
both were not the focus of our review but proved inescapable in discussions on drivers and barriers, as 
experienced in interviews. Table 3 presents an overview of the techniques with an attempt to depict the 
horizon of applications, disregarding the expected impact of regulation in the EU as far as possible.  
The most likely techniques to show strong developments in the near future are the genome editing ones, 
in particular CRISPR-Cas9. The “null segregant” concepts are promising for accelerating the breeding 
process and for producing F1 hybrid seeds. Some RNAi applications are already on the market outside of 
the EU and others may become relevant in the near future, e.g. “cross-kingdom” RNAi, but others, e.g. 
TGS (RdDM), at least in their variant of the end product not containing the transgenic silencing construct, 
are still awaiting effective examples; possibly, a better insight into mechanisms and stability of 
epigenetic changes will be helpful with the latter. In the synthetic biology field, applications in metabolic 
engineering may become relevant soon, particularly in bio-fortification, bio-based economy applications 
and possibly, pharmaceuticals. As with “classical” plant transformation, effects, intended as well as 
unintended, will largely depend on the type of trait introduced. Many of the traits are in the same 
categories as in “classical” transformation and/or conventional breeding, such as product quality, 
metabolites, abiotic and biotic stress tolerances, but are expected to be achieved with more efficiency 
and/or precision. We discussed some examples of alternative ways for achieving resistance and/or more 
precision attainable in resistances against pathogens and pests, in terms of plant performance and 
specificity for the target organism.  
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Table 2. Overview of different uses of transgenic constructs and technologies  
  For stable DNA integration into the 
genome.  
 
For stable DNA integration into the 
genome, but not in the end product.  
 
For transient expression.  
 
Delivery by Agrobacterium-mediated 
transformation or by direct DNA transfer 
(biolistic-, whisker-, PEG-, electroporation-
mediated) 
 
Delivery by Agrobacterium-mediated 
transformation or by direct DNA transfer 
(biolistic-, whisker-, PEG-, 
electroporation-mediated) 
 
Delivery by Agrobacterium-mediated 
transformation or by direct DNA transfer 
(transient expression from plasmid), 
mRNA, protein or ribonucleoprotein 
transfer. Also virus-mediated (for 
overexpression and VIGS) 
Intended for continuous presence of novel 
DNA sequences: 
 
 
 
 
 
 
-repair template DNA introduced by SSN-
induced HR 
-cisgenesis (eg R-genes); intragenesis 
-RNAi-PTGS, e.g. against insects (cross-
kingdom RNAi) 
-RNAi-TGS (maintained silencing) 
-CRISPR-Cas9 against DNA viruses 
-synthetic biology – metabolic pathways 
-rootstocks of grafted plants 
 
Intended as intermediate step and 
transgene will be removed in later 
generations (e.g. by segregation): 
 
 
 
 
 
-in genome editing (NHEJ or HR) 
-to facilitate, accelerate breeding 
(induced early flowering, several 
elements of hybrid variety breeding and 
hybrid seed production) 
-rootstocks of grafted plants: no 
transgene in scion products 
 
Intended for temporary presence of 
DNA, mRNA, protein or 
ribonucleoprotein (all these will be 
spontaneously degraded in the cell but 
DNA may also become stably integrated 
unintendedly and requires here check 
for absence):  
 
-mutation induction by ODM, SSN 
(NHEJ) 
-HR induction (SSN-HR) 
-RNAi-TGS (methylation pattern is 
maintained over generations) 
-RNAi-TGS (VIGS) 
-induced early flowering (virus) 
-signalling from rootstocks of grafted 
plants to scions and v.v.  
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Table 3. Overview of techniques with their applications, including the horizon basically without regard to barriers perceived with regulatory uncertainty in the EU.  
 
Technique Applications Barriers 
/ 
Drivers 
Horizon  
Genome editing: 
Oligo-directed 
mutagenesis (ODM) 
Wide array (potentially):  
(1) Herbicide tolerance (HT) 
(2) Modified product quality; stress 
tolerances biotic (S genes) & 
abiotic (drought), etc. 
 
Technically demanding: protoplast technology & 
selection efficiency 
Regulatory 
/ 
Precise mutagenesis method without use of 
transgenic constructs 
1 Short term: HT marketed 
outside EU 
2 Medium term: other types of 
traits 
Genome editing: 
Sequence-specific 
nucleases (SSNs): 
non-homologous end 
joining (NHEJ) 
Wide array (gene knock-out):  
HT; modified product quality; stress 
tolerances biotic (S genes) & abiotic, 
etc. 
 
Off-target effects 
Regulatory & IPR 
/ 
Precise mutagenesis method, could also be 
used by transient expression or “DNA-free” 
CRISPR variant relatively easily applied 
Genomics for gene functionality & identifying off-
target effects 
1 Short term: outside EU, one 
product considered outside of 
regulation by USDA-APHIS 
2 Medium term: CRISPR 
products 
Genome editing: 
Sequence-specific 
nucleases (SSNs): 
homologous 
recombination (HR) 
Wide array (incl. new genes/promoters & 
stacking):  
HT; modified product quality; stress 
tolerances biotic (R genes) & abiotic, 
etc. 
“Gene drive” 
 
Technically demanding: low HR efficiency (also 
for “gene drive”) 
Off-target effects 
Regulatory 
/ 
Precise method of mutagenesis/gene 
replacement or insertion at specified 
location/gene stacking 
Genomics for gene functionality & identifying off-
target effects 
1. Short term: proof of concept 
but no product marketed 
2. Medium term: possibly gene 
stacks; also allele 
replacement (latter still 
technically demanding) 
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Technique Applications Barriers 
/ 
Drivers 
Horizon 
Plant transformation 
(new variants): Plant 
transformation with 
transgenes not in end 
product 
 Induced early flowering for 
accelerated breeding in fruit trees 
(wide array of traits, e.g. biotic stress);  
 Suppression of meiotic recombination 
(reverse breeding), maintainer lines, 
or haploid inducers supporting hybrid 
breeding;  
 transgenic rootstocks (wide array of 
traits, e.g. soil-borne stresses) 
Regulatory 
/ 
Increased efficiency of breeding without 
transgenic constructs in end product; could also 
be used by transient expression (virus vector) in 
early flowering 
 
1. Short term: hybrid maintainer 
system used outside of EU; 
early flowering & transgenic 
rootstocks proof of concept 
but no product marketed yet 
2 Medium term: possibly 
haploid inducers  
Plant transformation 
(new variants): Plant 
transformation 
introducing genes 
from cross-compatible 
species 
 Cisgenesis: genes from cross-
compatible species, mainly R genes  
 Intragenesis: novel combinations of 
genes & promoters from cross-
compatible species: wide array of 
possibilities for changing gene 
expression levels and 
metabolic/developmental pathways 
Cis limitation to “native” genes 
Regulatory 
/ 
Cis use of “native” genes; intra wide possibilities 
(without introducing new genes) 
 
1 Short term: cis one product 
deregulated outside EU, 
which is a stack with an intra 
RNAi variant already 
marketed outside of EU 
2. Medium term: possibly other 
cis & intra products marketed 
RNAi: Post-
transcriptional gene 
silencing (PTGS) 
Wide array (gene silencing):  
modified product quality; stress 
tolerances biotic & abiotic, etc. 
Special variant: tolerance biotic stress 
through “cross-kingdom RNA” 
 
Silencing efficiency 
Off-target effects 
Alternative of topical application 
Regulatory (transgenic product) 
/ 
Precise method of silencing gene expression, 
incl. “cross-kingdom”, with dominant inheritance 
& potentially more subtle regulation of 
expression levels (as opposed to gene knock-
outs) 
Genomics for gene functionality & identifying off-
target effects 
1 Short term: intragenesis 
variants marketed outside of 
EU; a “cross-kingdom” RNAi 
variant deregulated in US and 
Canada 
2 Medium term: possibly more 
examples of “cross-kingdom” 
RNAi  
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Technique Applications Barriers 
/ 
Drivers 
Horizon 
RNAi: Transcriptional 
gene silencing (TGS) 
(RdDM) 
Wide array (gene silencing):  
modified product quality; stress 
tolerances biotic & abiotic, male 
sterility for hybrid breeding etc. 
 
Silencing efficiency & stability (with transgene 
removal) 
Off-target effects 
Regulatory (i.p. transgenic product variant) 
/ 
Precise method of silencing gene expression & 
potentially more subtle regulation of expression 
levels (as opposed to gene knock-outs); also 
possibility of using virus vector not carried over 
through meiosis or possibility of regenerating 
epigenetically changed plant from non-GM part 
of grafted plant 
Genomics for gene functionality & identifying off-
target effects & epigenetic stability 
1 Short term: research phase, 
i.p. variant with transgene 
removal 
2 Medium term: possibly 
variants maintaining 
transgene 
Synthetic biology  Introduction of novel pathways; "plant 
as factory" 
(pharmaceuticals/antibodies)  
 Site-specific activators/repressors 
(targeted activation or repression of 
gene expression by artificial factors 
affecting transcription or inducing 
epigenetic changes using 
combinations of active domains with 
SSN-derived DNA-binding domains)  
 Adapting CRISPR-Cas9 to targeting 
plant DNA viruses  
 Synthetic chromosomes 
Competitiveness with microbial systems & 
segregation from food chain for pharmaceuticals 
Regulatory (transgenic product) 
/ 
Possibility of producing valuable compounds or 
plants for pharma, and bio-economy & -
fortification 
1 Short term: one 
pharmaceutical authorised  
2 Medium term: bio-fortification 
& possibly bio-economy 
variants; others in research 
phase, i.p. synthetic 
chromosomes 
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Technique Applications Barriers 
/ 
drivers 
Horizon 
Modifying gene 
expression with 
exogenous 
compounds 
 Gene silencing by topical application 
of dsRNA:  
o to plant (parts);  
o to insects/pathogens  
 Agro-inoculation, VIGS  
 “DNA-free” genome editing (by SSN 
delivery as (ribonucleo)protein, mRNA 
or transient expression of SSN-genes 
in cells (see above) 
Topical application could compete with 
transgenic RNAi versions above but likely in 
regulatory realm outside scope of present study 
Agro-inoculation mainly research tool 
“DNA-free” genome editing, see above 
For most breeding companies 
outside of business model & 
outside scope of present study 
    
Other: regenerating 
species hybrid from 
graft junction 
Species cybrid or hybrid (potentially wide 
array of traits) 
Regulatory (transgenic selection markers) 
/ 
Possibly interesting development 
 
Two publications, in research 
phase 
    
Not addressed Transforming plant pest insects; algae   
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6. Abbreviations 
 
Bt Bacillus thuringiensis toxin 
CCE centromere-mediated chromosome elimination 
CRISPR-Cas clustered regularly interspaced short palindromic repeats – CRISPR-associated protein, a 
type of SSN 
DSB double-strand break 
dsRNA double-stranded RNA 
GT gene targeting 
HDR homology-driven repair 
HIGS host-induced gene silencing 
HR homologous recombination 
HT herbicide tolerance 
Indel insertion/deletion 
miRNA microRNA 
NGS next-generation sequencing 
NHEJ non-homologous end joining 
ODM oligo-directed mutagenesis 
PTGS post-transcriptional gene silencing 
RdDM RNA dependent DNA methylation 
RNAi RNA interference 
SDN site-directed nuclease, alternative name for SSN 
siRNA small interfering RNA 
SSN sequence-specific nuclease 
TALEN transcription activator-like effector nuclease, a type of SSN 
TGS transcriptional gene silencing 
ZFN zinc finger nuclease, a type of SSN 
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8. Annex 
Table 1. List of new techniques and/or developments in plant (“green”) biotechnology as used in the 
interviews.  
Theme Techniques Mode of action/examples Special 
Genome 
editing 
ODM oligo-directed 
mutagenesis  
 inducing DNA-corrections by a 
homology-dependent repair 
mechanism using 
oligonucleotides with 
mismatches as template: indels, 
nucleotide substitutions 
 
Genome 
editing 
Sequence-specific 
nucleases (SSNs): non-
homologous end joining 
(NHEJ) 
 inducing double strand breaks 
(DSBs) resulting in homologous-
independent DNA repair by 
NHEJ using SSNs (ZFN, 
Meganuclease, TALENS, 
CRISPR-Cas9): indels, 
nucleotide substitutions  
variant: non-
transgenic 
genome editing 
(by delivery of 
protein or 
transient 
expression into 
cells) 
Genome 
editing 
Sequence-specific 
nucleases (SSNs): 
homologous 
recombination (HR) 
 inducing double strand breaks 
(DSBs) resulting in homologous-
driven repair by HR using SSNs: 
targeted gene insertion, allele 
replacement 
 
Plant 
transformation 
(new variants) 
Plant transformation 
with transgenes not in 
end products 
 Induced early flowering for 
accelerated breeding in fruit 
trees;  
 suppression of meiotic 
recombination for reverse 
(hybrid) breeding;  
 transgenic rootstocks 
 
Plant 
transformation 
(new variants) 
Plant transformation 
introducing genes from 
cross-compatible 
species 
 Cisgenesis: introduction of genes 
from same or cross-compatible 
species  
 Intragenesis: introduction of 
novel combinations of genes & 
promoters from same or cross-
compatible species 
 
RNAi Post-transcriptional 
gene silencing (PTGS) 
 overexpression of gene-derived 
inverted repeats (dsRNA) for 
silencing gene expression: 
degradation of mRNA or 
translational repression directed 
by siRNAs or miRNAs 
“Cross-kingdom 
RNAi”: RNAi 
against pests and 
pathogens (host 
induced gene 
silencing HIGS) 
Special variants 
using 
transformed 
rootstock to 
deliver siRNA to 
non-GM scion 
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RNAi Transcriptional gene 
silencing (TGS) 
 gene silencing by promoter 
methylation induced by dsRNA 
from transgene subsequently 
removed from end product 
(RdDM) 
Special variants: 
Induced using 
virus not carried 
over through 
meiosis. 
Mobile small 
RNAs moving 
between shoot & 
root (grafted 
plants, possibility 
of regenerating 
epigenetically 
changed plant 
from non-GM 
part) 
Synthetic 
biology 
  Synthetic chromosomes  
 Site-specific 
activators/repressors (targeted 
activation or repression of gene 
expression by artificial factors 
affecting transcription or inducing 
epigenetic changes using 
combinations of active domains 
with SSN DNA-binding domains)  
 Introduction of novel pathways; 
"plant as factory" 
(pharmaceuticals/antibodies)  
 Adapting CRISPR-Cas9 to 
targeting plant DNA viruses 
 
    
Method of 
delivery 
Modifying gene 
expression without 
transformation 
 Gene silencing by application of 
dsRNA:  
o to plant (parts);  
o to insects/pathogens  
 Agro-inoculation, VIGS  
 non-transgenic genome editing 
(by SSN delivery as protein or 
transient expression in cells) 
Special variant: 
early flowering by 
promoting or 
silencing gene 
expression 
through virus 
vector not 
transmitted to 
progeny 
    
Other   regenerating species hybrid from 
graft junction 
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Questions per technique/concept: 
1. What is your expectation for commercial applications/product development? What types of 
products can be expected? 
1.1. Short term 
1.2. Medium term. Do you expect any new developments/refinements? What could be the 
contribution of supporting technologies such as genomics/Next Generation Sequencing to 
new developments? 
2. What do you see as drivers and what as barriers for application? 
2.1. Drivers 
2.2. Barriers 
 
3. Finally, are any new developments/technologies missing in this list? 
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